Alteration of neuropathic and vi sceral pain in female C57BL/6J mice lacking the PPAR-α gene

Psychopharmacology

Volumn 222, Issue 3, 2012, Pages 477-488

  Ruiz Medina, Jessica ^a   Flores, Juan A ^b   Tasset, Inmaculada ^c   Tunez, Isaac ^c   Valverde, Olga ^a   Fernandez Espejo, Emilio ^b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Allodynia; Hyperalgesia; Neuropathic pain; PPAR ; Pro inflammatory factors; Thermal sensitivity; Visceral nociception

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 3; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; DRUG DERIVATIVE; GW 6471; OXAZOLE DERIVATIVE; TYROSINE;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE; GENE FUNCTION; GENOTYPE; HEAT SENSITIVITY; HYPERALGESIA; MECHANICAL STIMULATION; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PPAR ALPHA GENE; PRIORITY JOURNAL; SCIATIC NERVE INJURY; STIMULUS RESPONSE; THERMAL STIMULATION; VISCERAL PAIN; WRITHING TEST; ANIMAL; C57BL MOUSE; MOUSE MUTANT; NEURALGIA; PHYSIOLOGY; SCIATIC NERVE;

ANIMALS; FEMALE; HYPERALGESIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURALGIA; OXAZOLES; PPAR ALPHA; SCIATIC NERVE; TYROSINE; VISCERAL PAIN;

EID: 84864439227     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2662-8     Document Type: Article

References (54)

1. Ahern GP (2003) Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 278:30429-30434
2. Bennett GJ, Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107
3. Brittain RT, Lehrer DN, Spencer PS (1963) Phenylquinone writhing test: Interpretation of data. Nature 200:895-896
4. Bura AS, Nadal X, Ledent C, Maldonado R, Valverde O (2008) A2A adenosine receptor regulates glia proliferation and pain after peripheral nerve injury. Pain 140:95-103
5. Chang SL, Kenigs V, Moldow RL, Zadina JE (1995) Chronic treatment with morphine and ethanol, but not cocaine, attenuates IL-1 beta activation of FOS expression in the rat hypothalamic paraventricular nucleus. Adv Exp Med Biol 373:201-208
6. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63
7. Chen XR, Besson VC, Palmier B, Garcia Y, Plotkine M, Marchand-Leroux C (2007) Neurological Recovery-Promoting, Anti-Inflammatory, and Anti-Oxidative Effects Afforded by Fenofibrate, a PPAR Alpha Agonist, in traumatic Brain Injury. J Neurotrauma 24:1119-1131
8. Cluny NL, Keenan CM, Lutz B, Piomelli D, Sharkey KA (2009) The identification of peroxisome proliferator-activated receptor alphaindependent effects of oleoylethanolamide on intestinal transit in mice. Neurogastroenterol Motil 21:420-429
9. Cuzzocrea S, Mazzon E, Di Paola R, Peli A, Bonato A, Britti D et al (2006) The role of the peroxisome proliferator-activated receptoralpha (PPAR-alpha) in the regulation of acute inflammation. J Leuk Biol 79:999-1010
10. Daynes RA, Jones DC (2002) Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2:748-759
11. DeLeo JA, Yezierski RP (2001) The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90:1-6
12. Drew PD, Xu J, Storer PD, Chavis JA, Racke MK (2006) Peroxisome proliferator-activated receptor agonist regulation of glial activation: Relevance to CNS inflammatory disorders. Neurochem Int 49:183-189
13. Espejo EF, Gil E (1998) Antagonism of peripheral 5-HT4 receptors reduces visceral and cutaneous pain in mice, and induces visceral analgesia after simultaneous inactivation of 5-HT3 receptors. Brain Res 788(1-2):20-24
14. Espejo EF, Mir D (1993) Structure of the rat's behaviour in the hot plate test. Behav Brain Res 56:171-176
15. Espejo EF, Stinus L, Cador M, Mir D (1994) Effects of morphine and naloxone on behaviour in the hot plate test: An ethopharmacological study in the rat. Psychopharmacology (Berl) 113:500-510
16. Flores CA, Cid LP, Sepúlveda FV (2010) Strain-dependent differences in electrogenic secretion of electrolytes across mouse colon epithelium. Exp Physiol 95:686-698
17. Franklin KBJ, Abbott FV (1989) Techniques for assessing the effects of drugs on nociceptive responses. In: Boulton AA, Baker GB, Greenshaw AJ (eds) Neuromethods: Psychopharmacology. Humana, New Jersey, pp 145-215
18. Genovese T, Esposito E, Mazzoni E, Di Paola R, Meli R, Bramanti P et al (2008) Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther 326:12-23
19. Gonzalez-Aparicio R, Flores JA, Tasset I, Tunez I, Fernandez-Espejo E (2011) Mice lacking the peroxisome proliferatoractivated receptor alpha gene present reduced number of dopamine neurons in the substantia nigra without altering motor behavior or dopamine neuron decline over life. Neuroscience 186:161-169
20. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88
21. Kono K, Kamijo Y, Hora K, Takahashi K, Higuchi M, Kiyosawa K et al (2009) PPAR alpha attenuates the proinflammatory response in activated mesangial cells. Am J Physiol Renal 29:F328-F336
22. Kostadinova R, Wahli W, Michalik L (2005) PPARs in diseases: Control mechanisms of inflammation. Curr Med Chem 12:2995-3009
23. Laird JM, Bennett GJ (1993) An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy. J Neurophysiol 69:2072-2085
24. LaPrairie JL, Muprhy AZ (2007) Female rats are more vulnerable to the long-term consequences of neonatal inflammatory injury. Pain 132:S124-S133
25. Leung L, Cahill CM (2010) TNF-alpha and neuropathic pain. J Neuroinflammation 7:27
26. Liang DY, Liao G, Wang J, Usuka J, GuoY PG et al (2006) A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology 104:1054-1062
27. Lleo A, Galea E, Sastre M (2007) Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases. Cell Mol Life Sci 64:1403-1418
28. LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, Meli R, Hohmann A, Calignano A, Piomelli D et al (2006) Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 319:1051-1061
29. Maeda T, Kishioka S (2009) PPAR and Pain. Int Rev Neurobiol 85:165-177
30. Malmberg AB, Basbaum AI (1998) Partial sciatic nerve injury in the mouse as a model of neuropathic pain: Behavioural and neuroanatomical correlates. Pain 76:215-222
31. Marx N, Kehrle B, Kohlhammer BK, Grub M, Koenig W, Hombach V, Libby P, Plutzky J et al (2002) PPAR activators as antiinflammatory mediators in human T lymphocytes: Implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res 90:703-710
32. Mickle A, Sood M, Zhang Z, Shahmohammadi G, Sengupta JN, Miranda A (2010) Antinociceptive effects of melatonin in a rat model of post-inflammatory visceral hyperalgesia: A centrally mediated process. Pain 149:555-564
33. Okamoto H, Iwamoto T, Kotake S, Momohara S,Yamanaka H, Kamatani N (2005) Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol 23:323-330
34. Ropero AB, Juan-Picó P, Rafacho A, Fuentes E, Bermúdez- Silva FJ, Roche E et al (2009) Rapid non-genomic regulation of Ca2+ signals and insulin secretion by PPAR alpha ligands in mouse pancreatic islets of Langerhans. J Endocrinol 200:127-138
35. Ruiz-Medina J, Ledent C, Carretón O, Valverde O (2011) GPR3 orphan receptor is involved in neuropathic pain after peripheral nerve injury. Neuropharmacology 61:43-50
36. Sandkühler J (2009) Models and Mechanisms of Hyperalgesia and Allodynia. Physiol Rev 89:707-758
37. Sewell RD, Spencer PS (1975) Anti-nociceptive activity of narcotic agonists and partial agonists in mice given biogenic amines by intracerebroventricular injection. Psychopharmacologia 42(1):67-71
38. Shah S, Sanford UR, Vargas JC, Xu H, Groen A, Paulusma CC et al (2010) Strain Background Modifies Phenotypes in the ATP8B1-Deficient Mouse. PLoS One 5:e8984
39. Shir Y, Seltzer Z (1990) A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci Lett 115(1):62-67
40. Shir Y, Seltzer Z (2001) Heat hyperalgesia following partial sciatic ligation in rats: Interacting nature and nurture. Neuroreport 12:809-813
41. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A et al (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 17:886-897
42. Smith SB, Crager SE, Mogil JS (2004) Paclitaxel-induced neuropathic hypersensitivity in mice: Responses in 10 inbred mouse strains. Life Sci 74:2593-2604
43. Sommer C (2003) Determining the diagnosis from the pain pattern. Brief and stabbing or chronic and dull? MMW Fortschr Med 145:30-33
44. Su HF, Samsamshariat A, Fu J, Shan YX, Chen YH, Piomelli D, Wang PH (2006) Oleylethanolamide activates Ras-Erk pathway and improves myocardial function in doxorubicin-induced heart failure. Endocrinology 147:827-834
45. Suardíaz M, Estivill-Torrus G, Goicoechea C, Bilbao A, Rodríguez de Fonseca F (2007) Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. Pain 133:99-110
46. Taylor BK, Dadia N, Yang CB, Krishnan S, Badr M (2002) Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia. Inflammation 26:121-127
47. van Eick AJ (1967) A change in the response of the mouse in the "hot plate" analgesia-test, owing to a central action of atropine and related compounds. Acta Physiol Pharmacol Neerl 14(4):499-500
48. Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G (2003) A paradigm for gene regulation: Inflammation, NF-kappaB and PPAR. Adv Exp Med Biol 544:181-196
49. Watkins LR, Maier SF (2003) Glia: A novel drug discovery target for clinical pain. Nat Rev Drug Discov 2:973-985
50. Wijnvoord N, Albuquerque B, Häussler A, Myrczek T, Popp L, Tegeder I (2010) Inter-strain differences of serotonergic inhibitory pain control in inbred mice. Mol Pain 6:70
51. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE et al (2002) Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415:813-817
52. Xu J, Storer PD, Chavis JA, Racke MK, Drew PD (2005) Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. J Neurosci Res 81:403-411
53. Xu J, Chavis JA, Racke MK, Drew PD (2006) Peroxisome proliferatoractivated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes. J Neuroimmunol 176:95-105
54. Xu J, Racke MK, Drew PD (2007) Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: Relevance to multiple sclerosis. J Neurochem 103:1801-1810